Literature DB >> 22627943

The involvement of Notch signaling in melanoma vasculogenic mimicry.

Amalia Vartanian1, Galina Gatsina, Irina Grigorieva, Elico Solomko, Vladislav Dombrovsky, Anatoly Baryshnikov, Eugenia Stepanova.   

Abstract

Notch signaling plays an important role in tumor angiogenesis. Recent studies suggest that Notch signaling also regulates the progression of primary melanomas toward an aggressive phenotype. The aim of this study was to investigate the involvement of Notch signaling pathway in organization of tumor cells into capillary-like structures (CLS), the phenomenon also known as vasculogenic mimicry (VM). Here, we show that Notch signaling cascade was constitutively active in melanoma cell lines we used. Blocking Notch signaling with the γ-secretase inhibitors, DAPT, dibenzazepine or Jagged1 neutralizing antibody resulted in stabilization of CLS indicating that Notch signaling pathway attenuates melanoma VM. We further studied this phenomenon on melanomas grafted in nude mice. Compared to control, VM channels in DAPT-treated grafted melanoma became larger and more branched. DAPT-treated melanomas also exhibited an up-regulation of MMP-2 and VEGFR1, both known as VM mediators. Moreover, we did not observe necrosis in VM channels areas of DAPT-treated melanomas. These findings indicate that VM regulated by Notch signaling may present a novel target in melanoma therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22627943     DOI: 10.1007/s10238-012-0190-9

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  30 in total

Review 1.  Pathways to melanoma.

Authors:  Justin M Ko; Nicole F Velez; Hensin Tsao
Journal:  Semin Cutan Med Surg       Date:  2010-12

Review 2.  Dynamics of endothelial cell behavior in sprouting angiogenesis.

Authors:  Hanna M Eilken; Ralf H Adams
Journal:  Curr Opin Cell Biol       Date:  2010-10       Impact factor: 8.382

3.  Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma.

Authors:  Daniela Massi; Francesca Tarantini; Alessandro Franchi; Milena Paglierani; Claudia Di Serio; Silvia Pellerito; Giuseppe Leoncini; Giuseppe Cirino; Pierangelo Geppetti; Marco Santucci
Journal:  Mod Pathol       Date:  2006-02       Impact factor: 7.842

Review 4.  VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: present and future.

Authors:  P Sapra Sharma; R Sharma; T Tyagi
Journal:  Curr Cancer Drug Targets       Date:  2011-06       Impact factor: 3.428

Review 5.  Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?

Authors:  Iris Helfrich; Dirk Schadendorf
Journal:  Mol Oncol       Date:  2011-02-03       Impact factor: 6.603

Review 6.  Notch signaling in the regulation of stem cell self-renewal and differentiation.

Authors:  Jianing Liu; Chihiro Sato; Massimiliano Cerletti; Amy Wagers
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

Review 7.  Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies.

Authors:  Jon C Aster; Stephen C Blacklow; Warren S Pear
Journal:  J Pathol       Date:  2010-10-21       Impact factor: 7.996

8.  VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.

Authors:  Natasha Y Frank; Tobias Schatton; Soo Kim; Qian Zhan; Brian J Wilson; Jie Ma; Karim R Saab; Veronika Osherov; Hans R Widlund; Martin Gasser; Ana-Maria Waaga-Gasser; Thomas S Kupper; George F Murphy; Markus H Frank
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

Review 9.  Delta-like 4/Notch signaling and its therapeutic implications.

Authors:  Minhong Yan; Greg D Plowman
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

10.  Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties.

Authors:  Leopoldo Luistro; Wei He; Melissa Smith; Kathryn Packman; Maria Vilenchik; Daisy Carvajal; John Roberts; James Cai; Windy Berkofsky-Fessler; Holly Hilton; Michael Linn; Alexander Flohr; Roland Jakob-Røtne; Helmut Jacobsen; Kelli Glenn; David Heimbrook; John F Boylan
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

View more
  19 in total

1.  Involvement of Notch1/Hes signaling pathway in ankylosing spondylitis.

Authors:  Wei Xu; Chao-Ge Liang; Yi-Fan Li; Yun-Han Ji; Wen-Jun Qiu; Xian-Zhong Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 2.  Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.

Authors:  Xiaoxu Wei; Yunhua Chen; Xianjie Jiang; Miao Peng; Yiduo Liu; Yongzhen Mo; Daixi Ren; Yuze Hua; Boyao Yu; Yujuan Zhou; Qianjin Liao; Hui Wang; Bo Xiang; Ming Zhou; Xiaoling Li; Guiyuan Li; Yong Li; Wei Xiong; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

3.  HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.

Authors:  Na-Na Tang; Hong Zhu; Hong-Jie Zhang; Wei-Feng Zhang; Hai-Lin Jin; Lu Wang; Pin Wang; Gui-Jun He; Bo Hao; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 4.  Histochemical Staining of Vasculogenic Mimicry.

Authors:  Saber Imani; Shuya Liu; Mazaher Maghsoudloo; QingLian Wen
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry.

Authors:  Elena Andreucci; Silvia Peppicelli; Jessica Ruzzolini; Francesca Bianchini; Lido Calorini
Journal:  Cancer Metastasis Rev       Date:  2022-10-13       Impact factor: 9.237

6.  Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.

Authors:  Caroline I Schnegg; Moon Hee Yang; Subrata K Ghosh; Mei-Yu Hsu
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

7.  High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.

Authors:  Wei Li; Min Liu; Yuan Feng; Yan-Fei Huang; Yun-Fei Xu; Jian-Ping Che; Guang-Chun Wang; Jun-Hua Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15

8.  Melanoma educates mesenchymal stromal cells towards vasculogenic mimicry.

Authors:  Amalia Vartanian; Saida Karshieva; Vladislav Dombrovsky; Alexander Belyavsky
Journal:  Oncol Lett       Date:  2016-05-05       Impact factor: 2.967

Review 9.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

10.  Obesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia.

Authors:  Dana M Niedowicz; Valerie L Reeves; Thomas L Platt; Katharina Kohler; Tina L Beckett; David K Powell; Tiffany L Lee; Travis R Sexton; Eun Suk Song; Lawrence D Brewer; Caitlin S Latimer; Susan D Kraner; Kara L Larson; Sabire Ozcan; Christopher M Norris; Louis B Hersh; Nada M Porter; Donna M Wilcock; Michael Paul Murphy
Journal:  Acta Neuropathol Commun       Date:  2014-06-10       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.